Mindfulness based stress reduction study design of a longitudinal randomized controlled complementary intervention in women with breast cancer

BMC Complementary and Alternative Medicine

Volumn 13, Issue , 2013, Pages

  Kenne Sarenmalm, Elisabeth ^a,b,c   Mårtensson, Lena B ^d   Holmberg, Stig B ^e   Andersson, Bengt A ^f   Odén, Anders ^g   Bergh, Ingrid ^d  

^a SKARABORG HOSPITAL   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c ERSTA HOSPITAL   (Sweden)

^d UNIVERSITY OF SKÖVDE   (Sweden)

^e SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^f UNIVERSITY OF GOTHENBURG   (Sweden)

^g CHALMERS UNIVERSITY OF TECHNOLOGY   (Sweden)

Author keywords

Breast cancer; Mindfulness based stress reduction; Randomized controlled trials; Well being

Indexed keywords

ANXIETY; ARTICLE; BREAST CANCER; CONTROLLED STUDY; COPING BEHAVIOR; DEPRESSION; EMPOWERMENT; FEMALE; HEALTH; HEALTH CARE QUALITY; HEALTH PROGRAM; HUMAN; IMMUNE RESPONSE; KNOWLEDGE; LONGITUDINAL STUDY; MINDFULNESS BASED STRESS REDUCTION; MOOD DISORDER; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; STRESS; STUDY DESIGN; TRAINING; WELLBEING;

BREAST NEOPLASMS; FEMALE; HUMANS; LONGITUDINAL STUDIES; MINDFULNESS; QUALITY OF LIFE; QUESTIONNAIRES; STRESS, PSYCHOLOGICAL; TREATMENT OUTCOME;

EID: 84884770463     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/1472-6882-13-248     Document Type: Article

References (68)

1. Morasso G, Costantini M, Viterbori P, Bonci F, Del Mastro L, Musso M, Garrone O, Venturini M. Predicting mood disorders in breast cancer patients. Eur J Canc 2001, 37(2):216-223.
2. Boehmke MM, Brown JK. Predictors of symptom distress in women with breast cancer during the first chemotherapy cycle. Can Oncol Nurs J 2005, 15(4):215-227. 10.5737/1181912x154215220, 16405206.
3. Hjerl K, Andersen EW, Keiding N, Mortensen PB, Jorgensen T. Increased incidence of affective disorders, anxiety disorders, and non-natural mortality in women after breast cancer diagnosis: a nation-wide cohort study in Denmark. Acta Psychiatr Scand 2002, 105(4):258-264. 10.1034/j.1600-0447.2002.9028.x, 11942929.
4. Maguire P. Managing psychological morbidity in cancer patients. Eur J Canc 2000, 36(5):556-558.
5. Bleiker EM, Pouwer F, van der Ploeg HM, Leer JW, Ader HJ. Psychological distress two years after diagnosis of breast cancer: frequency and prediction. Patient Educ Counsel 2000, 40(3):209-217.
6. Carver CS, Pozo C, Harris SD, Noriega V, Scheier MF, Robinson DS, Ketcham AS, Moffat FL, Clark KC. How coping mediates the effect of optimism on distress: a study of women with early stage breast cancer. J Pers Soc Psychol 1993, 65(2):375-390.
7. Epping-Jordan JE, Compas BE, Osowiecki DM, Oppedisano G, Gerhardt C, Primo K, Krag DN. Psychological adjustment in breast cancer: processes of emotional distress. Health Psychol 1999, 18(4):315-326.
8. Andrykowski MA, Curran SL, Studts JL, Cunningham L, Carpenter JS, McGrath PC, Sloan DA, Kenady DE. Psychosocial adjustment and quality of life in women with breast cancer and benign breast problems: a controlled comparison. J Clin Epidemiol 1996, 49(8):827-834. 10.1016/0895-4356(96)00028-5, 8699200.
9. Cordova MJ, Cunningham LL, Carlson CR, Andrykowski MA. Posttraumatic growth following breast cancer: a controlled comparison study. Health Psychol 2001, 20(3):176-185.
10. Kenne Sarenmalm E, Thoren-Jonsson AL, Gaston-Johansson F, Ohlen J. Making sense of living under the shadow of death: adjusting to a recurrent breast cancer illness. Qual Health Res 2009, 19(8):1116-1130. 10.1177/1049732309341728, 19638604.
11. Moyer A, Salovey P. Psychosocial sequelae of breast cancer and its treatment. Ann Behav Med 1996, 18(2):110-125.
12. Chida Y, Hamer M, Wardle J, Steptoe A. Do stress-related psychosocial factors contribute to cancer incidence and survival?. Nat Clin Prac Oncol 2008, 5(8):466-475.
13. Andersen BL, Farrar WB, Golden-Kreutz D, Kutz LA, MacCallum R, Courtney ME, Glaser R. Stress and immune responses after surgical treatment for regional breast cancer. J Natl Cancer Inst 1998, 90(1):30-36. 10.1093/jnci/90.1.30, 2743254, 9428780.
14. Thornton LM, Andersen BL, Crespin TR, Carson WE. Individual trajectories in stress covary with immunity during recovery from cancer diagnosis and treatments. Brain Behav Immun 2007, 21(2):185-194. 10.1016/j.bbi.2006.06.007, 2151213, 16908118.
15. Wiltschke C, Krainer M, Budinsky AC, Berger A, Muller C, Zeillinger R, Speiser P, Kubista E, Eibl M, Zielinski CC. Reduced mitogenic stimulation of peripheral blood mononuclear cells as a prognostic parameter for the course of breast cancer: a prospective longitudinal study. Br J Canc 1995, 71(6):1292-1296.
16. Yamasaki S, Kan N, Harada T, Ichinose Y, Moriguchi Y, Li L, Sugie T, Kodama H, Satoh K, Ohgaki K. Relationship between immunological parameters and survival of patients with liver metastases from breast cancer given immuno-chemotherapy. Breast Canc Res Treat 1993, 26(1):55-65.
17. Rao VS, Dyer CE, Jameel JK, Drew PJ, Greenman J. Potential prognostic and therapeutic roles for cytokines in breast cancer (Review). Oncol Rep 2006, 15(1):179-185.
18. Yokoe T, Iino Y, Morishita Y. Trends of IL-6 and IL-8 levels in patients with recurrent breast cancer: preliminary report. Breast Canc (Tokyo, Japan) 2000, 7(3):187-190.
19. Bachelot T, Ray-Coquard I, Menetrier-Caux C, Rastkha M, Duc A, Blay JY. Prognostic value of serum levels of interleukin 6 and of serum and plasma levels of vascular endothelial growth factor in hormone-refractory metastatic breast cancer patients. Br J Canc 2003, 88(11):1721-1726.
20. Salgado R, Junius S, Benoy I, Van Dam P, Vermeulen P, Van Marck E, Huget P, Dirix LY. Circulating interleukin-6 predicts survival in patients with metastatic breast cancer. Int J Canc 2003, 103(5):642-646.
21. Fawzy FI, Fawzy NW, Arndt LA, Pasnau RO. Critical review of psychosocial interventions in cancer care. Arch Gen Psychiatr 1995, 52(2):100-113. 10.1001/archpsyc.1995.03950140018003, 7848046.
22. Sheard T, Maguire P. The effect of psychological interventions on anxiety and depression in cancer patients: results of two meta-analyses. Br J Canc 1999, 80(11):1770-1780.
23. Chambless DL, Hollon SD. Defining empirically supported therapies. J Consult Clin Psychol 1998, 66(1):7-18.
24. Luecken LJ, Compas BE. Stress, coping, and immune function in breast cancer. Ann Behav Med 2002, 24(4):336-344. 10.1207/S15324796ABM2404_10, 12434945.
25. Kabat-Zinn J. Wherever you go, there you are: Mindfulness meditation for everyday life 1994, London: Piatkus.
26. Kabat-Zinn J, Massion AO, Kristeller J, Peterson LG, Fletcher KE, Pbert L, Lenderking WR, Santorelli SF. Effectiveness of a meditation-based stress reduction program in the treatment of anxiety disorders. J Am Psychiatr 1992, 149(7):936-943.
27. Plews-Ogan M, Owens JE, Goodman M, Wolfe P, Schorling J. A pilot study evaluating mindfulness-based stress reduction and massage for the management of chronic pain. J Gen Intern Med 2005, 20(12):1136-1138. 10.1111/j.1525-1497.2005.0247.x, 1490272, 16423104.
28. Speca M, Carlson LE, Goodey E, Angen M. A randomized, wait-list controlled clinical trial: the effect of a mindfulness meditation-based stress reduction program on mood and symptoms of stress in cancer outpatients. Psychosom Med 2000, 62(5):613-622.
29. Baer RA. Mindfulness training as a clinical intervention: A conceptual and empirical review. Clin Psychol Sci Pract 2003, 10(2):125-143.
30. Grossman P, Niemann L, Schmidt S, Walach H. Mindfulness-based stress reduction and health benefits. A meta-analysis. J Psychosom Res 2004, 57(1):35-43. 10.1016/S0022-3999(03)00573-7, 15256293.
31. Lee SH, Ahn SC, Lee YJ, Choi TK, Yook KH, Suh SY. Effectiveness of a meditation-based stress management program as an adjunct to pharmacotherapy in patients with anxiety disorder. J Psychosom Res 2007, 62(2):189-195. 10.1016/j.jpsychores.2006.09.009, 17270577.
32. Toneatto T, Nguyen L. Does mindfulness meditation improve anxiety and mood symptoms? A review of the controlled research. Can J Psychiatry Revue canadienne de psychiatrie 2007, 52(4):260-266.
33. Witek-Janusek L, Albuquerque K, Chroniak KR, Chroniak C, Durazo-Arvizu R, Mathews HL. Effect of mindfulness based stress reduction on immune function, quality of life and coping in women newly diagnosed with early stage breast cancer. Brain Behav Immun 2008, 22(6):969-981. 10.1016/j.bbi.2008.01.012, 2586059, 18359186.
34. Branstrom R, Kvillemo P, Brandberg Y, Moskowitz JT. Self-report mindfulness as a mediator of psychological well-being in a stress reduction intervention for cancer patients-a randomized study. Ann Behav Med 2010, 39(2):151-161. 10.1007/s12160-010-9168-6, 20177843.
35. Branstrom R, Kvillemo P, Akerstedt T. Effects of mindfulness training on levels of cortisol in cancer patients. Psychosomatics 2013, 54(2):158-164. 10.1016/j.psym.2012.04.007, 23218058.
36. Carlson LE, Speca M, Patel KD, Goodey E. Mindfulness-based stress reduction in relation to quality of life, mood, symptoms of stress, and immune parameters in breast and prostate cancer outpatients. Psychosom Med 2003, 65(4):571-581. 10.1097/01.PSY.0000074003.35911.41, 12883107.
37. Carlson LE, Speca M, Faris P, Patel KD. One year pre-post intervention follow-up of psychological, immune, endocrine and blood pressure outcomes of mindfulness-based stress reduction (MBSR) in breast and prostate cancer outpatients. Brain Behav Immun 2007, 21(8):1038-1049. 10.1016/j.bbi.2007.04.002, 17521871.
38. Carlson LE, Speca M, Patel KD, Goodey E. Mindfulness-based stress reduction in relation to quality of life, mood, symptoms of stress and levels of cortisol, dehydroepiandrosterone sulfate (DHEAS) and melatonin in breast and prostate cancer outpatients. Psychoneuroendocrinology 2004, 29(4):448-474. 10.1016/S0306-4530(03)00054-4, 14749092.
39. Altman DG, Schulz KF, Moher D, Egger M, Davidoff F, Elbourne D, Gotzsche PC, Lang T, Consort G. The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med 2001, 134(8):663-694. 10.7326/0003-4819-134-8-200104170-00012, 11304107.
40. Zwarenstein M, Treweek S, Gagnier JJ, Altman DG, Tunis S, Haynes B, Oxman AD, Moher D, group C Improving the reporting of pragmatic trials: an extension of the CONSORT statement. Bmj 2008, 337:a2390. 10.1136/bmj.a2390, 3266844, 19001484, group C.
41. Boutron I, Moher D, Altman DG, Schulz KF, Ravaud P, Group C. Methods and processes of the CONSORT Group: example of an extension for trials assessing nonpharmacologic treatments. Ann Intern Med 2008, 148(4):W60-W66.
42. SBU Metoder för behandling av långvarig smärta: En systematisk litteraturöversikt 2006, Stockholm: Statens beredning för medicinsk utvärdering, SBU.
43. The Swedish Breast Cancer Group National Guidelines. Breast Cancer Treatment 2008, http://www.swebcg.se, The Swedish Breast Cancer Group.
44. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983, 67(6):361-370. 10.1111/j.1600-0447.1983.tb09716.x, 6880820.
45. Mykletun A, Stordal E, Dahl AA. Hospital Anxiety and Depression (HAD) scale: factor structure, item analyses and internal consistency in a large population. Br J Psychiatry 2001, 179:540-544. 10.1192/bjp.179.6.540, 11731359.
46. Herrmann C. International experiences with the Hospital Anxiety and Depression Scale-a review of validation data and clinical results. J Psychosom Res 1997, 42(1):17-41. 10.1016/S0022-3999(96)00216-4, 9055211.
47. Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the hospital anxiety and depression scale. An updated literature review. J Psychosom Res 2002, 52(2):69-77. 10.1016/S0022-3999(01)00296-3, 11832252.
48. Antonovsky A. Unraveling the mysteries of health: how people manage stress and stay well 1987, San Francisco: Jossey-Bass.
49. Antonovsky A. The structure and properties of the sense of coherence scale. Soc Sci Med 1993, 36(6):725-733. 10.1016/0277-9536(93)90033-Z, 8480217.
50. Eriksson M, Lindstrom B. Validity of Antonovsky's sense of coherence scale: a systematic review. J Epidemiol Community Health 2005, 59(6):460-466. 10.1136/jech.2003.018085, 1757043, 15911640.
51. Langius A, Bjorvell H, Antonovsky A. The sense of coherence concept and its relation to personality traits in Swedish samples. Scand J Caring Sci 1992, 6(3):165-171. 10.1111/j.1471-6712.1992.tb00146.x, 1439378.
52. Gilbar O. Coping with threat. Implications for women with a family history of breast cancer. Psychosomatics 1998, 39(4):329-339. 10.1016/S0033-3182(98)71321-0, 9691702.
53. Thome B, Hallberg IR. Quality of life in older people with cancer - a gender perspective. Eur J Canc Care 2004, 13(5):454-463.
54. Portenoy RK, Thaler HT, Kornblith AB, Lepore JM, Friedlander-Klar H, Kiyasu E, Sobel K, Coyle N, Kemeny N, Norton L, et al. The memorial symptom assessment scale: an instrument for the evaluation of symptom prevalence, characteristics and distress. Eur J Canc 1994, 30A(9):1326-1336.
55. Tranmer JE, Heyland D, Dudgeon D, Groll D, Squires-Graham M, Coulson K. Measuring the symptom experience of seriously ill cancer and noncancer hospitalized patients near the end of life with the memorial symptom assessment scale. J Pain Symptom Manag 2003, 25(5):420-429.
56. Hurny C, Bernhard J, Bacchi M, van Wegberg B, Tomamichel M, Spek U, Coates A, Castiglione M, Goldhirsch A, Senn HJ, et al. The Perceived Adjustment to Chronic Illness Scale (PACIS): a global indicator of coping for operable breast cancer patients in clinical trials. Swiss Group for Clinical Cancer Research (SAKK) and the International Breast Cancer Study Group (IBCSG). Support Care Cancer 1993, 1(4):200-208. 10.1007/BF00366447, 8193882.
57. Bernhard J, Thurlimann B, Schmitz SF, Castiglione-Gertsch M, Cavalli F, Morant R, Fey MF, Bonnefoi H, Goldhirsch A, Hurny C. Defining clinical benefit in postmenopausal patients with breast cancer under second-line endocrine treatment: does quality of life matter?. J Clin Oncol 1999, 17(6):1672-1679.
58. McHorney CA, Ware JE, Lu JF, Sherbourne CD. The MOS 36-item short-form health survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med care 1994, 32(1):40-66. 10.1097/00005650-199401000-00004, 8277801.
59. Sullivan M, Karlsson J, Ware JE. The Swedish SF-36 health survey--I. Evaluation of data quality, scaling assumptions, reliability and construct validity across general populations in Sweden. Soc Sci Med 1995, 41(10):1349-1358. 10.1016/0277-9536(95)00125-Q, 8560302.
60. Persson LO, Karlsson J, Bengtsson C, Steen B, Sullivan M. The Swedish SF-36 health survey II. Evaluation of clinical validity: results from population studies of elderly and women in Gothenborg. J Clin Epidemiol 1998, 51(11):1095-1103. 10.1016/S0895-4356(98)00101-2, 9817127.
61. Sullivan M, Karlsson J. The Swedish SF-36 health survey III. Evaluation of criterion-based validity: results from normative population. J Clin Epidemiol 1998, 51(11):1105-1113. 10.1016/S0895-4356(98)00102-4, 9817128.
62. Tedeschi RG, Calhoun LG. The posttraumatic growth inventory: measuring the positive legacy of trauma. J Trauma Stress 1996, 9(3):455-471. 10.1002/jts.2490090305, 8827649.
63. Smith SG, Cook SL. Are reports of posttraumatic growth positively biased?. J Trauma Stress 2004, 17(4):353-358. 10.1023/B:JOTS.0000038485.38771.c6, 15462544.
64. Baer RA, Smith GT, Hopkins J, Krietemeyer J, Toney L. Using self-report assessment methods to explore facets of mindfulness. Assessment 2006, 13(1):27-45. 10.1177/1073191105283504, 16443717.
65. Glaser B, Strauss A. The Discovery of Grounded Theory: Strategies for qualitative research 1967, New York: Aldine de Gruyter.
66. Glaser B. Theoretical sensitivity 1978, Mill Valley, CA: Sociology Press.
67. Personal Data Act Swedish codes of statues. Min of Justice 1998, 1998:204. Personal Data Act.
68. Biobanks in Medical Care Act Swedish codes of statues. SFS 2002, 2002:297. Biobanks in Medical Care Act.